Krueger, James G <br/><br/>
Effect of therapeutic integrin (CD11a) blockade with efalizumab on immune responses to model antigens in humans: results of a randomized, single blind study.  [electronic resource] 

 -  The Journal of investigative dermatology  Nov 2008 
 - 2615-2624 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1038/jid.2008.98  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Bacterial--metabolism<br/>Antibodies, Monoclonal--immunology<br/>Antibodies, Monoclonal, Humanized<br/>Antibody Formation--drug effects<br/>Antigens, Bacterial--pharmacology<br/>B-Lymphocytes--drug effects<br/>Bacteriophage phi X 174--immunology<br/>CD11a Antigen--drug effects<br/>Female<br/>Humans<br/>Immunoglobulin G--metabolism<br/>Immunoglobulin M--metabolism<br/>Male<br/>Middle Aged<br/>Pneumococcal Vaccines--pharmacology<br/>Psoriasis--drug therapy<br/>Single-Blind Method<br/>Skin Tests<br/>T-Lymphocytes--drug effects<br/>Tetanus Toxoid--pharmacology